Personal information

No personal information available

Activities

Employment (1)

University of Pittsburgh: Pittsburgh, Pennsylvania, US

2022-04-01 to present | Professor of Medicine in Division of Hematology/Medical Oncology (Medicine)
Employment
Source: Self-asserted source
Charles Edward Geyer Jr

Works (16)

Long-term outcomes by lobular vs ductal histology in 4 National Surgical Adjuvant Breast and Bowel Project adjuvant breast cancer trials

JNCI: Journal of the National Cancer Institute
2025-01-01 | Journal article
Contributors: Julia Foldi; Neil Carleton; Stewart J Anderson; Priya Rastogi; Adrian Lee; Marija Balic; Charles E Geyer, Jr; Steffi Oesterreich; Norman Wolmark
Source: check_circle
Crossref

Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial

Journal of Clinical Oncology
2024-10-20 | Journal article
Contributors: Priya Rastogi; Hanna Bandos; Peter C. Lucas; Laura J. van ‘t Veer; Jia-Perng J. Wei; Charles E. Geyer, Jr; Louis Fehrenbacher; Stephen K.L. Chia; Adam M. Brufsky; Janice M. Walshe et al.
Source: check_circle
Crossref

Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial

Clinical Cancer Research
2024-05-01 | Journal article
Contributors: Eleftherios P. Mamounas; Hanna Bandos; Priya Rastogi; Yi Zhang; Kai Treuner; Peter C. Lucas; Charles E. Geyer, Jr; Louis Fehrenbacher; Stephen K. Chia; Adam M. Brufsky et al.
Source: check_circle
Crossref

Data from Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial

2024-05-01 | Preprint
Contributors: Eleftherios P. Mamounas; Hanna Bandos; Priya Rastogi; Yi Zhang; Kai Treuner; Peter C. Lucas; Charles E. Geyer; Louis Fehrenbacher; Stephen K. Chia; Adam M. Brufsky et al.
Source: check_circle
Crossref

Data from Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial

2024-05-01 | Preprint
Contributors: Eleftherios P. Mamounas; Hanna Bandos; Priya Rastogi; Yi Zhang; Kai Treuner; Peter C. Lucas; Charles E. Geyer; Louis Fehrenbacher; Stephen K. Chia; Adam M. Brufsky et al.
Source: check_circle
Crossref

Supplementary Figure S1 from Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial

2024-05-01 | Preprint
Contributors: Eleftherios P. Mamounas; Hanna Bandos; Priya Rastogi; Yi Zhang; Kai Treuner; Peter C. Lucas; Charles E. Geyer; Louis Fehrenbacher; Stephen K. Chia; Adam M. Brufsky et al.
Source: check_circle
Crossref

Supplementary Figure S1 from Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial

2024-05-01 | Preprint
Contributors: Eleftherios P. Mamounas; Hanna Bandos; Priya Rastogi; Yi Zhang; Kai Treuner; Peter C. Lucas; Charles E. Geyer; Louis Fehrenbacher; Stephen K. Chia; Adam M. Brufsky et al.
Source: check_circle
Crossref

Supplementary Figure S2 from Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial

2024-05-01 | Preprint
Contributors: Eleftherios P. Mamounas; Hanna Bandos; Priya Rastogi; Yi Zhang; Kai Treuner; Peter C. Lucas; Charles E. Geyer; Louis Fehrenbacher; Stephen K. Chia; Adam M. Brufsky et al.
Source: check_circle
Crossref

Supplementary Figure S2 from Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial

2024-05-01 | Preprint
Contributors: Eleftherios P. Mamounas; Hanna Bandos; Priya Rastogi; Yi Zhang; Kai Treuner; Peter C. Lucas; Charles E. Geyer; Louis Fehrenbacher; Stephen K. Chia; Adam M. Brufsky et al.
Source: check_circle
Crossref

Supplementary Table from Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial

2024-05-01 | Preprint
Contributors: Eleftherios P. Mamounas; Hanna Bandos; Priya Rastogi; Yi Zhang; Kai Treuner; Peter C. Lucas; Charles E. Geyer; Louis Fehrenbacher; Stephen K. Chia; Adam M. Brufsky et al.
Source: check_circle
Crossref

Supplementary Table from Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial

2024-05-01 | Preprint
Contributors: Eleftherios P. Mamounas; Hanna Bandos; Priya Rastogi; Yi Zhang; Kai Treuner; Peter C. Lucas; Charles E. Geyer; Louis Fehrenbacher; Stephen K. Chia; Adam M. Brufsky et al.
Source: check_circle
Crossref

Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology])

Journal of Clinical Oncology
2024-04-20 | Journal article
Contributors: Charles E. Geyer, Jr; Joanne L. Blum; Greg Yothers; Lina Asmar; Patrick J. Flynn; Nicholas J. Robert; Judith O. Hopkins; Joyce A. O'Shaughnessy; Priya Rastogi; Shannon L. Puhalla et al.
Source: check_circle
Crossref

Precision medicine for metastatic TNBC: the FUTURE is now

Cell Research
2023-05-08 | Journal article
Contributors: Julia Foldi; Charles E. Geyer, Jr
Source: check_circle
Crossref

Adjuvant trastuzumab emtansine in HER2-positive breast cancer patients with HER2-negative residual invasive disease in KATHERINE

npj Breast Cancer
2022-09-19 | Journal article
Contributors: Sibylle Loibl; Chiun-Sheng Huang; Max S. Mano; Eleftherios P. Mamounas; Charles E. Geyer, Jr; Michael Untch; Jean-Christophe Thery; Ingo Schwaner; Steven Limentani; Niklas Loman et al.
Source: check_circle
Crossref

NRG Oncology/NSABP B-47 menstrual history study: impact of adjuvant chemotherapy with and without trastuzumab

npj Breast Cancer
2021-05-20 | Journal article
Contributors: Patricia A. Ganz; Reena S. Cecchini; Louis Fehrenbacher; Charles E. Geyer, Jr; Priya Rastogi; John P. Crown; Michael P. Thirlwell; David M. Ellison; Jean-Francois Boileau; Patrick J. Flynn et al.
Source: check_circle
Crossref

NSABP B-41, a Randomized Neoadjuvant Trial: Genes and Signatures Associated with Pathologic Complete Response

Clinical Cancer Research
2020-08-15 | Journal article
Contributors: Sandra M. Swain; Gong Tang; Heather Ann Brauer; David S. Goerlitz; Peter C. Lucas; André Robidoux; Brent T. Harris; Hanna Bandos; Yuqi Ren; Charles E. Geyer, Jr et al.
Source: check_circle
Crossref

Peer review (4 reviews for 2 publications/grants)

Review activity for Cell research (1)
Review activity for NPJ breast cancer. (3)